SynBio brings together Russian and international technology and know-how for the purpose of creating innovative new medicines. We are engaged in original research and the introduction of conceptually new medicines, including medicines known as Biobetters. These medicines help treat some of the most devastating and socially significant diseases: liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus, among others. Our work is based on the latest scientific developments and is conducted in cutting-edge laboratories in order to guarantee that our products correspond to the highest quality standards.

09 августа 2011

HSCI Announces Terms of the Investment Agreement on SynBio Project

HSCI is the final signatory among the participating companies...
RUSNANO OJSC Human Stem Cells Institute Pharmsyntez